APA
Díaz-Pedroche C., Lumbreras C., San Juan R., Folgueira D., Andrés A., Delgado J., Meneu J. C., Morales J. M., Moreno-Elola A., Hernando S., Moreno-González E. & Aguado J. M. (20060823). Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. : Transplantation.
Chicago
Díaz-Pedroche Carmen, Lumbreras Carlos, San Juan Rafael, Folgueira Dolores, Andrés Amado, Delgado Juan, Meneu Juan Carlos, Morales José María, Moreno-Elola Almudena, Hernando Susana, Moreno-González Enrique and Aguado José María. 20060823. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. : Transplantation.
Harvard
Díaz-Pedroche C., Lumbreras C., San Juan R., Folgueira D., Andrés A., Delgado J., Meneu J. C., Morales J. M., Moreno-Elola A., Hernando S., Moreno-González E. and Aguado J. M. (20060823). Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. : Transplantation.
MLA
Díaz-Pedroche Carmen, Lumbreras Carlos, San Juan Rafael, Folgueira Dolores, Andrés Amado, Delgado Juan, Meneu Juan Carlos, Morales José María, Moreno-Elola Almudena, Hernando Susana, Moreno-González Enrique and Aguado José María. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. : Transplantation. 20060823.